期刊文献+

缓解期B系淋巴瘤患者外周血T细胞亚群检测 被引量:6

Peripheral blood T lymphocyte subsets of patients with B cell lymphoma in the stage of complete response
下载PDF
导出
摘要 目的评估处于临床缓解期B系淋巴瘤患者的细胞免疫状态。方法应用流式细胞分析技术检测我院2010年11月至2014年7月处于临床缓解期的34例B系淋巴瘤患者外周血T细胞亚群。结果缓解期B系淋巴瘤患者外周血CD3^+、CD3^+CD4^+T淋巴细胞亚群及CD4^+/CD8^+均低于健康对照组(P<0.05);惰性B系淋巴瘤患者外周血CD3^+、CD3^+CD4^+、CD3^+CD56^+T淋巴细胞亚群及CD4^+/CD8^+均较侵袭性B系淋巴瘤患者高(P<0.05)。结论缓解期B系淋巴瘤患者仍存在细胞免疫功能低下,且侵袭性较惰性淋巴瘤免疫功能紊乱更严重。 Objective To assess the cellular immune function of patients with B cell lymphoma in the stage of complete response.Methods Totally 34 diagnosed B cell lymphoma in the stage of complete response from November 2010 to July 2014 were analyzed the peripheral blood T lymphocyte subsets by flow cytometry. Results The peripheral blood CD3~+,CD4~+T lymphocyte and CD4~+/CD8~+ ratios were lower in B cell lymphoma than in healthy control. The peripheral blood CD3~+,CD3~+CD4~+,CD3~+CD56~+T lymphocyte and CD4~+/ CD8~+ ratios were higher in indolent lymphoma compared to invasive lymphoma. Conclusion Patients with B cell lymphoma in the stage of complete response were still in low cellular immune function,especially with invasive lymphoma.
出处 《临床军医杂志》 CAS 2016年第1期11-13,共3页 Clinical Journal of Medical Officers
基金 辽宁省科技计划课题(2011225021 2013225089)
关键词 淋巴瘤 T细胞亚群 完全缓解 Lymphoma T lymphocyte subsets Complete response
  • 相关文献

参考文献10

二级参考文献84

共引文献55

同被引文献69

  • 1Tefferi A, Vardiman JW. Classification and diagnosis ofmyeloproliferative neoplasms: the 2008 World Health Organizationcriteria and point-of-care diagnostic algorithms [J]. Leukemia, 2008;22: 14-22.
  • 2Hauck G, Jonigk D, Kreipe H, et al. Simultaneous and sequentialconcurrent myeloproliferative and lymphoproliferative neoplasms [J].Acta Haematol; 2013,129: 187-196.
  • 3Gabrail NY, Martin TW. Coexistence of essential thrombocythemiaand chronic lymphocytic leukemia[J]. Acta Haematol) 1991, 85: 31-33.
  • 4Hern圣ndez-Boluda JC, Cervantes F, Alvarez A, et al. Non-Hodgkinslymphoma following untreated essential thrombocythemia[J]. LeukLymphoma; 2000, 36: 421-423.
  • 5Palandri F; Derenzini E, Ottaviani E, et al. Association of essentialthrombocythemia and non-Hodgkin lymphoma: a single-centreexperience [J], Leuk Lymphoma, 2009,50:481-484.
  • 6Vannucchi AM, Masala G, Antonioli E, et al. Increased risk oflymphoidneoplasms in patients with Philadelphia chromosome-negativemyeloproliferative neoplasms [J], Cancer Epidemiol Biomarkers Prev,2009,18: 2068-2073.
  • 7Rumi E, Passamonti F, Elena C, et al. Increased risk of lymphoidneoplasm in patients with myeloproliferative neoplasm: a study of 1,915patients[J]. Haematologica, 2011; 96: 4S4-4S8.
  • 8Laurenti L, Tarnani M, Nichele I, et al. The coexistence of chroniclymphocytic leukemia and myeloproliperative neoplasms: aretrospective multicentric GIMEMA experience[J]. Am J Hematol,2011, 86: 1007-1012.
  • 9Tirefort Y, Pham XC, Ibrahim YL, et al. A rare case of primarycutaneous follicle centre lymphoma presenting as a giant tumourof the scalp and combined with JAK2V617F positive essentialthrombocythaemia[J]. Biomark Res, 2014, 2(1): 7.
  • 10Dubey P, Chul SH, Pelayo CB, et al. Localized primary malignantlymphoma of bone[J]. Int J Radiat Oncol Biol Phys, 1997, 37(5):1087-1093.

引证文献6

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部